
Covivio S.A (COV) | Financial Analysis & Statements
Covivio S.A. | Large-cap | Real Estate
Covivio S.A. | Large-cap | Real Estate
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
1.3B
Gross Profit
977.0M
76.60%
Operating Income
800.7M
62.78%
Net Income
197.4M
15.48%
EPS (Diluted)
€0.64
Balance Sheet Metrics
Total Assets
24.9B
Total Liabilities
12.9B
Shareholders Equity
12.0B
Debt to Equity
1.07
Cash Flow Metrics
Operating Cash Flow
8.2B
Free Cash Flow
3.8B
Revenue & Profitability Trend
Covivio S.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 1.3B | 1.2B | 906.0M | 866.3M | 866.8M |
Cost of Goods Sold | 298.5M | 283.9M | 69.3M | 73.0M | 65.9M |
Gross Profit | 977.0M | 942.6M | 836.7M | 793.3M | 801.0M |
Operating Expenses | 138.1M | 135.4M | 125.2M | 134.6M | 143.9M |
Operating Income | 800.7M | 794.4M | 763.9M | 656.6M | 645.5M |
Pre-tax Income | 220.9M | -2.1B | 1.3B | 1.5B | 453.4M |
Income Tax | 23.5M | -207.3M | 137.9M | 169.0M | 61.1M |
Net Income | 197.4M | -1.9B | 1.1B | 1.3B | 392.3M |
EPS (Diluted) | €0.64 | -€14.55 | €6.57 | €9.73 | €3.82 |
Income Statement Trend
Covivio S.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | 2.2B | 2.2B | 1.7B | 2.9B | 2.3B |
Non-Current Assets | 22.7B | 22.8B | 25.9B | 25.3B | 25.0B |
Total Assets | 24.9B | 25.0B | 27.7B | 28.2B | 27.4B |
Liabilities | |||||
Current Liabilities | 2.3B | 2.2B | 1.9B | 2.8B | 2.6B |
Non-Current Liabilities | 10.6B | 10.9B | 11.6B | 11.8B | 12.3B |
Total Liabilities | 12.9B | 13.1B | 13.6B | 14.6B | 14.8B |
Equity | |||||
Total Shareholders Equity | 12.0B | 12.0B | 14.1B | 13.6B | 12.6B |
Balance Sheet Composition
Covivio S.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 2.0B | -19.0B | 1.1B | 1.3B | 392.3M |
Operating Cash Flow | 8.2B | 10.1B | 721.4M | 1.5B | 730.8M |
Investing Activities | |||||
Capital Expenditures | -770.0M | 1.4B | 119.5M | 64.7M | 58.3M |
Investing Cash Flow | -1.5B | 1.4B | 302.0M | -10.6M | -669.1M |
Financing Activities | |||||
Dividends Paid | -764.0M | -73.0M | -353.3M | -339.6M | -74.1M |
Financing Cash Flow | -5.8B | -5.4B | -1.3B | -593.6M | 358.8M |
Free Cash Flow | 3.8B | 5.4B | 130.2M | -8.9M | -130.6M |
Cash Flow Trend
Covivio S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
81.59
Forward P/E
11.79
Price to Book
0.69
Price to Sales
5.09
PEG Ratio
11.79
Profitability Ratios
Profit Margin
6.09%
Operating Margin
94.12%
Return on Equity
1.65%
Return on Assets
2.40%
Financial Health
Current Ratio
0.95
Debt to Equity
90.76
Beta
1.37
Per Share Data
EPS (TTM)
€0.63
Book Value per Share
€74.27
Revenue per Share
€10.47
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
cov | 5.7B | 81.59 | 0.69 | 1.65% | 6.09% | 90.76 |
Compagnie du | 6.4B | 150.00 | 1.18 | 0.76% | 128.75% | 0.73 |
Pluxee NV | 2.7B | 16.24 | 8.46 | 69.29% | 13.10% | 305.61 |
Carmila S.A | 2.3B | 7.51 | 0.69 | 9.36% | 59.74% | 80.62 |
Medincell S.A | 565.5M | -18.81 | - | 61.33% | -66.50% | -1.44 |
Valneva SE | 409.5M | 70.64 | 2.11 | -44.11% | -43.21% | 120.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.